LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCLSalma Parvin, Izidore S. Lossos, Ariel Ramírez-Labrada et al.|Cancer Cell|2019Cited by 98
Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single InstitutionJuan Pablo Alderuccio, Izidore S. Lossos, Wei Zhao et al.|Journal of Clinical Oncology|2018Cited by 79
Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentationJuan Pablo Alderuccio, Izidore S. Lossos, Wei Zhao et al.|American Journal of Hematology|2019Cited by 36
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphomaJuan Pablo Alderuccio, Izidore S. Lossos, Jean L. Koff et al.|Blood|2023Cited by 14
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populationsCaroline S. Myers, Juan Carlos Ramos, Denis Miyashiro et al.|Haematologica|2024Cited by 7